Institute of Clinical Physiology-National Research Council of Italy (IFC-CNR), Pisa, Italy.
Department of Emergency and Organ Transplantation, School and Chair of Allergology and Clinical Immunology, University of Bari Aldo Moro, Bari, Italy.
Eur Ann Allergy Clin Immunol. 2020 May;52(3):100-103. doi: 10.23822/EurAnnACI.1764-1489.136. Epub 2020 May 5.
A systematic review of the current literature on retreatment with omalizumab of patients with relapsing chronic spontaneous urticaria was performed. Published evidence shows that retreatment is safe and clinically effective, and that time to complete clinical response reduces as the number of retreatments increases.
对奥马珠单抗治疗复发性慢性自发性荨麻疹患者的现有文献进行了系统性回顾。已发表的证据表明，再次治疗是安全且临床有效的，且随着治疗次数的增加，达到临床缓解的时间缩短。
